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Hypersensitivity Pneumonitis (HP) is a lung inflammatory disorder caused by inhalation of
organic particles by a susceptible host. Since only a small proportion of individuals exposed
to HP-related antigens develop the disease, a genetic predisposition is largely suspected. How-
ever, studies regarding genetic susceptibility in this disease are scanty. We have previously
found evidence supporting increased risk associated to the major histocompatibility complex
(MHC) in sporadic HP. In the present study, we conducted a family-based research that includes
nine multicase families with at least two related HP patients (RHP). We evaluated 19 RHP in-
dividuals, 25 additional healthy first-degree relatives (REA) and 246 healthy unrelated individ-
uals (HUI). HLA class II typing (DRB1/3/4/5, DQA1, DQB1, DPA1, DPB1, DMA and DMB), and -863,acional de Enfermedades Respiratorias “Ismael Cosı´o Villegas”, Tlalpan 4502, CP 14080 Me´xico DF,
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212 R. Falfa´n-Valencia et al.-308 and -238 polymorphisms in the promoter region of TNF-a were performed by PCR based
methods. We identified an increased frequency of HLA-DRB1*04:07, DRB1*04:05, DRB1*11:01
and DRB1*13:01 alleles in RHP individuals compared to healthy controls (p < 0.05). A significant
higher frequency of DRB1*04:07-DQB1*03:02, DRB1*04:05-DQB1*03:02, and DRB1*04:03-
DQB1*03:02 haplotypes was also detected in the group of patients. Likewise, TNF-238 GG ge-
notype was more frequent in the RHP group as compared to REA (pZ 0.01, ORZ 7.2). Finally,
the combination of HLA-DRB1*04 alleles and TNF-238 GG was significantly increased in the RHP
group (pZ 0.01, ORZ 6.93). These findings indicate that genes located within the MHC region
confer susceptibility to familial HP in Mexicans.
ª 2013 Published by Elsevier Ltd.Introduction
Hypersensitivity pneumonitis (HP) is an immunological dis-
ease caused by exposure to a wide variety of organic par-
ticles in susceptible individuals [1]. The disease is likely the
result from a complex interaction between environmental
and genetic factors. In Mexico, pigeon breeder’s disease
provoked by inhalation of avian antigens is the most com-
mon form of HP. The clinical presentation is heterogeneous,
and patients may develop acute, sub-acute or chronic
forms of the disease and some of them may evolve to pul-
monary fibrosis [1,2].
Importantly, only a small proportion of exposed in-
dividuals develop the disease indicating that susceptibility
genes might be involved in the pathophysiology of the dis-
order [3]. We and others have found that susceptibility to
sporadic HP is associated to genes located within the major
histocompatibility complex (MHC) [4e9]. The presence of
several cases in the same family seems to be uncommon
and interestingly is particularly found in pediatric patients
[10,11].
Up to date no genetic studies on the familial form of HP
have been reported. MHC encodes a variety of molecules,
which are involved in the antigen processing and presenta-
tion as part of the adaptive immune response, and the in-
teractions with NK cells [12,13]. Polymorphisms in the
promoter region of the TNF gene have also been associated
with increased risk to a number of inflammatory diseases
[14,15]. On this regard, two single nucleotide polymorphisms
(SNPs) at -308 and -238 in the promoter region gene have
been commonly studied [16e18]. In sporadic HP, TNF-308A is
associated with high TNF-a production in vitro, and its gene
frequency is significantly increased in HP patients [19].
In the present study we aimed to explore the role of
polymorphisms of class II MHC genes (HLA-DRB1/3/4/5,
-DQA1, -DQB1, -DPA1, -DPB1, -DMA and -DMB) as well as the
TNF gene promoter region (MHC class III) in familial (mul-
ticase) HP.Material and methods
Study population
Nine families with at least two related HP patients (RHP)
were studied. Diagnosis of HP induced by avian antigens was
established as described previously [1,3,20]. Briefly, allpatients had indoor exposure to birds and positive serum
antibodies against avian antigens. Chest high-resolution
computed tomography scanning showed centrilobular
poorly defined micronodules, ground glass attenuation, and
focal air trapping, and the bronchoalveolar lavage displayed
>40% lymphocytes. Lung biopsy was performed in 45% of the
patients and histology confirmed the diagnosis of HP.
We also included two groups of healthy controls: 1)
twenty five first-degree relatives, exposed to the same
antigens but asymptomatic (REA) at the time of the study,
according a complete clinical history, physical examination,
serum antibodies against avian antigens, chest X-rays, and
pulmonary function tests. Also, they did not have history of
collagen-vascular disorders, diabetes, autoimmune or
chronic-degenerative disease; 2) 246 Mexican admixed
healthy unrelated individuals (HUI) with no family history of
HP. Mean age of these controls was 38.2  15.3 years. There
were 126 females (51%) and 120 males (49%). Patients, first-
degree relatives and healthy unrelated individuals had at
least two generations that were born in Mexico; therefore
they were considered to be Mexican Mestizo. This group is
genetically well characterized with a proportion of 56%
Indian genes, 40% Caucasian genes and 4% black genes
[21,22].
The Institutional Review Board of the National Institute
of Respiratory Diseases (Committee of Science and
Bioethics in Research, INER) reviewed and approved the
protocol (protocol B19-08) for genetic studies under which
all subjects were recruited. All subjects provided written
informed consent, and they authorized the storage of their
DNA samples at INER repositories for this study. In this study
we did not collected samples from minors/children, only
young adults older than 18 years were included.
Genomic DNA isolation
Genomic DNA was extracted from peripheral blood using a
BDtract genomic DNA isolation kit (Maxim Biotech, San
Francisco CA).
HLA class II typing
Molecular typing for DRB1/3/4/5, DQA1, DQB1, DMA, DMB,
DPA1, DPB1 loci and TNF-238, -308 and -863 polymorphisms
was done by PCR sequence-specific primers (PCR-SSP)
technique using the Fastype HLA-DNA SSP Typing System
(Biosynthesis Inc., Dallas TX). Initially HLA-DRB1 typing was
Table 1 Frequencies of HLA-DRB1 and DQB1 alleles in
familial HP, asymptomatic relatives, and unrelated healthy
individuals.
DRB1 RHP (n Z 19) REA (n Z 25) HUI (n Z 246)
n AF n AF n AF
04:07 6 0.157a 2 0.040 58 0.117
04:05 4 0.105b 3 0.060 1 0.002
11:01 4 0.105c 6 0.120 6 0.012
13:01 4 0.105d 3 0.060 12 0.025
08:02 3 0.078 5 0.100 95 0.194
16:02 3 0.078 4 0.080 31 0.064
04:03 2 0.052 2 0.040 10 0.021
03:01 2 0.052 3 0.060 16 0.032
14:06 2 0.052 3 0.060 49 0.100
01:01 1 0.026 3 0.060 9 0.019
04:04 1 0.026 ND 32 0.066
11:04 1 0.026 1 0.020 8 0.017
09:01 1 0.026 3 0.060 1 0.002
10:01 1 0.026 1 0.020 6 0.012
15:03 1 0.026 ND 1 0.002
04:02 ND 1 0.020 6 0.021
15:01 ND 4 0.080 18 0.036
Others 2 0.052 6 0.040 133 0.017
DQB1
03:02 14 0.368 9 0.18 120 0.245
03:01 14 0.368 17 0.34 122 0.247
04:02 4 0.105 6 0.12 101 0.205
02:01 3 0.078 6 0.12 18 0.036
05:01 2 0.052 5 0.1 33 0.068
06:02 1 0.026 7 0.14 18 0.036
Others 0 0 80 <0.036
a RHP vs REA, p Z 0.04, OR Z 5.7, 95% CI Z 1.0e36.7.
b RHP vs HUI, p Z 0.001, OR Z 51.1, 95% CI Z 6.2e531.1.
c RHP vs HUI, p Z 0.057 OR Z 9.5, 95% CI Z 2.5e35.3.
d RHP vs HUI, p Z 0.399 OR Z 4.7, 95% CI Z 1.4e15.3.
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DRB1/3/4/5 specificities in 24 independent reactions.
Allelic discrimination for HLA-DRB1*03, *04, *08, *11, *13
and *14 was performed with a panel of 16 primer pairs for
each one, whilst DRB1*01, *07, *12, *15 and *16 subtyping
included a panel of 8 primers pairs in each case.
For DQA1 and DQB1 loci two independent primer sets (16
and 24 primer pairs) were used. DQA1 typing covers 15 al-
leles up to DQA1*06:01 while DQB1 high-resolution kit in-
cludes 55 alleles in all altogether for DQ5, DQ6, DQ2, DQ3
and DQ4. DMA, DMB, DPA1 loci was done in a high resolution
modality; primers set for DMA locus identify 4 alleles (01:01
up to 01:04), using a combination of 4 primers, whereas
DMB locus employee 7 primers combinations. DPA1 locus
analysis included 23 alleles, from 01:03:01 up to 04:01 using
15 primers combinations. Finally, DPB1 alleles were
analyzed with a 48 primers set, this system allow identi-
fying alleles from 01:01 to 99:01.
TNF-238, -308 and -863 polymorphisms typing
TNF-238G/ A, -308G/ A and -863C/ A genotyping was
analyzed by PCR-SSP. A 410 bp genomic fragment of the
human G3PDH gene was co-amplified as internal control. All
PCR amplifications were performed on 75 ng of genomic
DNA in a 10 ml reaction volume containing 50 mMKCl,
10 mMTris-Cl, pH 8.3, 1.5 mM MgCl2; 60 mM of each dNTPs.
PCR conditions were 1 hold 96 C 1 min, 94 C 20 s, 65
1 min during 10 cycles, 94 C 20 s, 61 C 50 s, and 72 C 30 s
during 20 cycles and final extension 72 C 5 min in a
GeneAmp PCR system 9700 (Applied Biosystems, Foster
City, CA, USA). All amplifications were performed using
Platinum Taq DNA polymerase (Invitrogen, Brazil). PCR-SSP
products were electrophoresed in ethidium bromide 2%
agarose gels. The information for primer design was ach-
ieved from IMGT/HLA database [23].
Statistical analysis
Allele and genotype frequencies of HLA and TNF alleles
were determined by direct counting. Associations were
assessed by Fisher’s exact test at significance level
(<0.05). Odds ratios (OR) and 95% confidence intervals (CI)
were also calculated using the STATA v10 software. Geno-
type frequencies were tested by HardyeWeinberg
equilibrium.
Results
Nine families with a total of nineteen HP patients (eight
siblings pairs and one father, daughter and son trio, 13 fe-
males and 6 males; 59.67  16.01 years-old) and twenty-
five healthy first-degree relatives (19 females, 6 males;
39.95  14.23 years-old) were included in this study.
HLA class II alleles and haplotypes
The distributions of DRB1, DQA1 and DQB1 alleles are listed in
Table 1. Seventeen HLA-DRB1 alleles were detected in the
group of individuals with familial HP (RHP). Nine of them hadallele frequency (AF) higher than 5%, and the most common
HLA-DRB1 alleles were DRB1*04:07 (AF Z 0.157), and
DRB1*04:05, DRB1*11:01, and DRB1*13:01 (AFZ 0.105). We
identified an increased frequency of HLA-DRB1*04:07, HLA-
DRB1*04:05, *11:01 and *13:01 alleles in the group of RHP
compared to REA and HUI. In general a lower frequency of
alleles considered as highly representative of Amerindian
populations (DRB1*08:02 and *14:06) were detected in RHP
when compared to healthy unrelated controls.
Six alleles were revealed at the DQB1 locus, and among
them, DQB1*03:02 and DQB1*03:01 were the most frequent
in all groups. Interestingly, a higher frequency of the allele
DQB1*03:02 (AF Z 0.368) was detected in the RHP group
compared with REA individuals (AF Z 0.180) and unrelated
controls (AFZ 0.245). In contrast, a lower frequency of the
allele DQB1*04:02 was observed in RHP (AF Z 0.105)
whereas this allele has a frequency of 0.205 in healthy
unrelated controls.
We also compared the frequency of DRB1-DQB1 haplo-
types (HF) observed in patients with familial HP with those
observed in REA individuals and unrelated controls. As shown
in Table 2, we observed a significant higher frequency of the
haplotypes DRB1*04:07-DQB1*03:02 (HF Z 0.157),
DRB1*04:05-DQB1*03:02 (HF Z 0.105) and DRB1*04:03-
Table 2 Frequent HLA-DRB1-DQB1 haplotypes in patients
with familial HP, asymptomatic relatives, and unrelated
healthy individuals.
Haplotype
DRB1-DQB1
RHP
(n Z 19)
REA (nZ 25) HUI (nZ 246)
n HF n HF n HF
04:07e03:02 6 0.157 2 0.040 53 0.113
08:02e04:02 4 0.105 6 0.120 89 0.192
13:01e03:01 4 0.105 4 0.080 ND
11:01e03:01 4 0.105 6 0.120 2 0.004
04:05e03:02 4 0.105a 3 0.060 1 0.002
04:03e03:02 3 0.078 1 0.020 10 0.021
16:02e03:01 3 0.078 2 0.040 30 0.064
14:06e03:01 2 0.052 3 0.060 46 0.098
03:01e02:01 2 0.052 3 0.060 15 0.032
11:04e03:01 1 0.026 1 0.020 8 0.017
09:01e02:01 1 0.026 3 0.060 ND
10:01e05:01 1 0.026 2 0.040 5 0.01
04:04e03:02 1 0.026 ND 29 0.062
01:01e05:01 1 0.026 3 0.060 9 0.019
Others 1 0.026 9 0.040 195 0.017
a RHP vs HUI, p  0.0001 OR Z 65.3, 95% CI Z 6.8e621.4.
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with REA and healthy unrelated non-HP individuals. Inter-
estingly, the haplotype DRB1*11:01-DQB1*03:01 was most
frequent in both RHP and REA individuals compared to
healthy unrelated controls. No significant differences in the
distribution of HLA-DQA1 alleles were observed.
Regarding DPA1 and DPB1 loci, we distinguished four and
ten alleles respectively. In the DPA1 locus the highest fre-
quencies were for the alleles *02:03 and *02:02 that rep-
resented more than 80% in both groups of study. With
respect to the DPB1 locus, the alleles *04:02 and *04:01
were the most frequent alleles and no differences in their
frequency were detected among groups. Allele frequencies
of HLA-DMA among RHP patients and controls showed that
90% of the DMA alleles are represented by the specificities
*01:01 and *01:04 in both groups; the same effect was
observed in DMB subtypes, where almost 80% are *01:01 and
*01:03 alleles in RHP and REA groups.
In order to determine the ancestral characteristics of
MHC class II haplotypes of the RHP individuals we analyzed
the distribution of Amerindian, Caucasian, African and
Asian DRB1-DQA1-DQB1-DPA1-DPB1 haplotypes in RHP
(Table 3). We observed that 15/38 (39.4%) of haplotypes
were Amerindian specific whereas 7/38 (18.4%) were from
Caucasian specific origin. Asian specific haplotypes were
found in 2 homozygous individuals (4/38 haplotypes, 10.5%)
and African haplotypes were 2/38 (5.2%). Seven percent of
the DRB1-DQA1-DQB1-DPA1-DPB1 haplotypes were shared
between Amerindians, Caucasians and Asian.
TNF gene promoter polymorphisms
Table 4 shows the frequency distribution of TNF promoter
genotypes in RHP patients (n Z 18) and REA (n Z 22)
subjects. In the HP patients group, the most common ge-
notypes were -863CC, -308GG and -238GG, whereas in theexposed first degree relatives the most frequent combina-
tions were -863CC, and -308 GA, with a similar distribution
of the -238GG and GA genotypes. Thus, an increased fre-
quency of TNF-238 GG was observed in RHP patients
(p Z 0.01, OR Z 7.2, 95% CI Z 1.30e39.80) with a signif-
icant decrease of -238 GA.
Additionally, we analyzed the frequency of TNF-238 GG
genotype and HLA-DRB1*04 allele in RHP patients compared
with the REA group. We found this combination in 13 out of
the 18 RHP (72%) patients and only in 8 of the 22 REA group
(36%) (p Z 0.01, OR Z 6.9, 95% CI Z 1.4e35.4).Discussion
HP is a complex immunopathological disease mediated by an
exaggerated T-cell immune response. Since only a small
proportion of individuals exposed to HP-related antigens
develop the disease, a genetic predisposition is largely sus-
pected. However, studies regarding genetic susceptibility to
HP are scanty. In general, case-control studies evaluating
genetic susceptibility to HP have been performed in small
cohorts of sporadic cases and genome-wide association
studies have not been reported. So far, MHC genes, primarily
from class II region, have been identified as key factors that
contribute to the susceptibility to sporadic HP.4e6
Here we examined the putative implication of the HLA
system in 9 families with at least two cases of HP. We
evaluated the polymorphisms of HLA-DRB1/3/4/5, DQA1,
DQB1, DPA1, DPB1, DMA and DMB loci and 3 polymorphisms
at TNF promoter (-863, -308 and -238). We found a higher
frequency of the HLA-DRB1*04:07, DRB1*04:05, DRB1*11:01
and DRB1*13:01 alleles in individuals with familial HP.
Importantly, the HLA-DRB1*04 alleles have been associated
with increased risk to several autoimmune diseases; for
instance, evidence indicates that S57-LLEQRRAA (67e74)
epitope in the third hypervariable region of the HLA-
DRB1*04:05/*04:10 molecule is relevant to the predisposi-
tion to autoimmunity [24]. This susceptibility epitope is
shared by the alleles found in this study and it would be also
important for the development of HP since the nonpolar
alanine at residue 74 could increase the affinity of antigenic
peptide(s) to the HLA-DR4 molecule and/or T cell receptor
recognition. The shared epitope containing HLA-DRB1 al-
leles such as DRB1*0405 have been associated with the
susceptibility and severity of rheumatoid arthritis (RA) in
different ethnic groups [25e27]. RA is the most prevalent
autoimmune disease and an important percentage of these
patients develop rheumatoid associated interstitial lung
disease [28,29]. Despite the immune alterations in HP have
been extensively studied, the immunopathogenic mecha-
nisms of the disease are not fully understood. Recent
studies have reported a defective regulatory T cell function
in HP, possibly contributing to the loss of immune tolerance
[30]. Functional studies are needed to explore the possible
connection between autoimmunity and the pathogenesis of
HP.
In addition, polymorphisms in the HLA-DRB1 region have
been associated with differences in gene expression, indi-
cating that the association of this region with disease may be
the result of altered gene expression levels besides to the
effect of structural variants to antigen recognition [31].
Table 3 HLA class II haplotypes in Mexican patients with familial HP.
Family Patient ID DRB1 DQA1 DQB1 DPA1 DPB1 Ethnicity
1 ILD343 Haplotype 1 04:03 03:01 03:02 02:03 04:02 As, Am, Cauc
Haplotype 2 11:04 05:05 03:01 02:02 04:02 Cauc
1 ILD344 Haplotype 1 04:03 03:01 03:02 02:03 04:02 As, Am, Cauc
Haplotype 2 08:02 04:01 04:02 03:02 04:02 Am
2 ILD366 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 16:02 05:01 03:01 02:02 05:01 Am
2 ILD367 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 09:01 04:01 02:01 03:02 04:02 Af, Am
3 ILD409 Haplotype 1 08:02 04:01 04:02 03:02 04:02 Am
Haplotype 2 10:01 01:01 05:01 02:02 17:01 Af
3 ILD417 Haplotype 1 04:04 03:01 03:02 02:03 04:02 Cauc, Am
Haplotype 2 14:06 05:03 03:01 02:03 04:02 Am
4 ILD481 Haplotype 1 03:01 05:01 02:01 02:03 01:01 Cauc
Haplotype 2 13:01 05:01 03:01 02:02 04:01 Possibly Cauc
4 ILD495 Haplotype 1 03:01 05:01 02:01 02:03 01:01 Cauc
Haplotype 2 13:01 05:01 03:01 02:02 04:01 Possibly Cauc
5 ILD571 Haplotype 1 16:02 05:01 03:01 02:02 04:02 Am
Haplotype 2 11:01 05:05 03:01 02:03 04:01 Cauc
5 ILD572 Haplotype 1 16:02 05:01 03:01 02:02 04:02 Am
Haplotype 2 11:01 05:05 03:01 02:03 04:01 Cauc
6 ILD577 Haplotype 1 11:01 05:05 03:01 02:03 04:02 Cauc
Haplotype 2 15:03 01:02 06:02 02:03 04:02 Af
6 ILD116 Haplotype 1 04:03 03:01 03:02 02:03 04:02 As, Am, Cauc
Haplotype 2 08:02 04:01 04:02 03:02 04:02 Am
7 ILD762 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 14:06 05:03 03:01 02:03 04:01 Am
7 ILD763 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 13:01 05:01 03:01 02:02 04:01 Possibly Cauc
7 ILD761 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 13:01 05:01 03:01 02:02 04:01 Possibly Cauc
8 ILD786 Haplotype 1 01:01 01:01 05:01 02:02 04:02 Cauc
Haplotype 2 11:01 05:05 03:01 02:03 03:01 Cauc
8 ILD785 Haplotype 1 04:07 03:01 03:02 02:03 04:02 Am
Haplotype 2 08:02 04:01 04:02 03:02 15:02 Am
9 ILD840 Haplotype 1 04:05 03:02 03:02 02:03 04:02 As
Haplotype 2 04:05 03:02 03:02 02:03 14:01 As
9 ILD841 Haplotype 1 04:05 03:02 03:02 02:03 04:02 As
Haplotype 2 04:05 03:02 03:02 02:03 14:01 As
As: Asian; Am: Amerindian; Cauc: Caucasian; Af: African.
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and DRB1*14:06, highly representative of Amerindian
groups, was lower in RHP in contrast to individuals without
HP (REA and healthy unrelated controls). This result is
similar to our previous findings in Mexican admixed in-
dividuals with sporadic HP where a significant decrease in
the frequency of HLA-DRB1*08:02 was also noticed, sug-
gesting that this allele may have a protective role.
An increased frequency of DQB1*03:02 and a lower fre-
quency of DQB1*04:02 was also observed in patients with
familial HP, and the haplotype analysis revealed a signifi-
cant increase in the frequency of HLA-DRB1*04:07-
DQB1*03:02, DRB1*04:05-DQB1*03:02 and DRB1*04:03-
DQB1*03:02 haplotypes in the RHP group. Interestingly, it
has recently reported that individuals positive for HLA-
DRB1*04 with DQB1*03:02 have the highest risk of devel-
oping type 1 diabetes [32]. Also, the DQB1*03:02 allele, incombination with DQA1*03 variant in cis position on DR4
haplotype (DRB1*04-DQA1*03:01-DQB1*03:02) is found in
patients with increased risk to celiac disease [33,34]. These
findings indicate that a diverse group of immune-regulated
disorders without much overlap in clinical presentation or
etiology may share risk locus in the HLA system. Inappro-
priate expression of DQB1 alleles or differential transcrip-
tional response of specific alleles to cytokine stimuli may
contribute to their role in disease associations and immune
activation. Thus, functional assays that analyzed HLA-DQB1
expression in HLA-DQB1*03:01/*03:02 heterozygous skin fi-
broblasts, showed that the HLA-DQB1*03:02 allele respon-
ded much more slowly to induction by IFN-g than HLA-
DQB1*03:01 allele [35].
We also determined the distribution and ethnicity of the
MHC class II haplotypes in RHP patients and the results were
similar to previous reports with Mexican population [21,22].
Table 4 TNF-238, -308 and -863 genotype frequencies in
RHP patients and REA subjects.
TNF
genotypes
RHP
(n Z 18)
REA
(n Z 22)
p OR CI (95%)
n GF n GF
-863
CC 12 0.667 17 0.773 0.49 0.59 0.11e2.97
CA 5 0.278 5 0.227 0.73 1.31 0.24e7.01
AA 1 0.056 ND e 0.45 Und. Und.
-308
GG 11 0.611 6 0.273 0.06 4.19 0.93e19.68
GA 7 0.389 16 0.727 0.06 0.24 0.05e1.08
AA ND e ND e
-238
GG 16 0.889 11 0.500 0.01 7.2 1.30e39.80
GA 2 0.111 10 0.455 0.04 0.15 0.02e0.81
AA ND e 1 0.045 1.0 Und. Und.
Definition of abbreviations: GF: Genotype frequency. OR: Odds
ratio. CI: Confidence interval. ND: Not detected. Und: Unde-
fined. Statistically significant values are shown in bold.
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vary in different ethnic groups. In this study we detected an
increased frequency of DRB1*11:01 and DRB1*13:01 alleles,
commonly observed in Caucasians. In contrast, RHP in-
dividuals exhibited a lower frequency of HLA-DRB1*08:02
and DRB1*14:06 which are alleles highly frequent in Amer-
indians, suggesting that these may have a protective role
[36].
We also analyzed the distribution of TNF-a promoter
polymorphism in RHP and REA individuals. TNF-a is a pro-
inflammatory cytokine produced primarily in Th1-like
microenvironment, as occurs in hypersensitivity pneumo-
nitis, and secreted predominantly by monocytes/macro-
phages. At the gene level, it has two common functional
polymorphisms in the promoter region located at positions
-238 and -308, both are substitutions of adenine for gua-
nine; the -308 polymorphism is a G / A transition
(rs1800629) which affects gene expression, with the minor
A allele resulting in higher TNF-a production [37]. Few
studies have analyzed the role of the TNF-a promoter
polymorphisms, in the production of soluble TNF-a and they
have given contradictory results. Thus, functional studies
have reported higher levels of TNF-a production in in-
dividuals with the genotype homozygous -238 GG while
lower levels of TNF-a and the allele -238 G has been
described in sarcoidosis and rheumatoid arthritis [38e41].
Previous studies in Caucasians reported a significant in-
crease of the TNF-308 A allele in patients with sporadic HP
[19]. Supporting these findings we also reported the asso-
ciation between the heterozygous -308 GA genotype with
sporadic HP in Mexican admixed individuals [4].
By contrast, in this study dealing with familial HP, we
detected a higher frequency of the heterozygous -308 GA
genotype in REA patients when compared to HP patients.
The lack of association of -308 A allele in this study might
be related to some differential mechanisms of HP suscep-
tibility between sporadic and familial HP. We also observed
an increase in the frequency of the promoter allele variantTNF-238G in the RHP group and almost all of these patients
were homozygous. This finding is relevant because TNF-
238G polymorphism, similarly to the TNF-308 poly-
morphism, may also contribute to the over-production of
TNF-a, or may be in linkage disequilibrium with neighboring
genes that influence disease predisposition and/or its
severity. Alternatively, since a significant number of pa-
tients carried the HLA-DRB1*04 allele in combination with
TNF-238 GG genotype (ORZ 6.93) and the possible linkage
disequilibrium between these alleles, our findings may
indicate that both TNF and DRB1 loci could be relevant in
the susceptibility to familial HP generating a strong pro-
inflammatory reaction after cell activation in the respira-
tory tract triggered by inhaled antigens.
Our study has some limitations, including its relatively
small sample size, restricted by the study’s focus on pa-
tients with familial HP, which is remarkably lesser common
than sporadic HP. In addition, we chose not to include pa-
tients with non-confirmed diagnosis of HP or with first-
degree relatives with history of inflammatory disorders.
Certainly, this cohort size limits the discussion about the
possible functional mechanisms. With this stringently
defined number of cases, we used a significance level of
p < 0.05. A second limitation is our inability to include a
replication cohort, despite we collaborate with other clin-
ical investigators interested in HP pathogenesis in others
countries.
In summary, this study shows that, as reported in spo-
radic HP, the pathophysiology of familial HP is also influ-
enced by the HLA genes and particularly, a gene-to-gene
interaction between TNF-238G homozygous and HLA-
DRB1*04 alleles and haplotypes may contribute to the sus-
ceptibility to HP in Mexicans.
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